INSIGHTS ON DRUG DEVELOPMENT

• Key Metrics In Antibody Drug Development

  Explore key techniques like DSC and Rheology to assess thermal stability and viscosity in antibody drug development. Gain practical insights to enhance biologic candidate selection, formulation, and delivery.

• Spray Dried Biologics For Pulmonary Dosage Forms

  Spray drying creates stable inhalable biologic powders with controlled particle size, enabling effective lung delivery, improved stability, and scalable production for respiratory and systemic therapies.

• Improving API Solubility Using Spray Drying With Polyvinyl Alcohol

  Enhancing the solubility of poorly soluble APIs is vital for improving bioavailability. Discover how advanced formulation techniques like hot-melt extrusion and spray drying can overcome this challenge.

• Strategic Early Material Generation For Accelerated Process Development

  Learn how early material generation strategies can accelerate biologics development, streamline process optimization, and enable scalable, production-relevant material supply from the earliest stages of development.

• ADC Manufacturing: Practices, Challenges, And The Road Ahead

  6/15/2026

  ADCs are advancing quickly, but manufacturing complexity is rising just as fast. Key challenges in scale-up, regulation, and costs are reshaping how the next generation of therapies will be delivered.

• Navigating Emerging Therapeutics: Cannabinoid And Psilocybin Drug Development

  1/15/2026

  Cannabinoid and psilocybin therapies are advancing rapidly, and Mikart supports innovators with DEA-licensed facilities, formulation expertise, regulatory guidance, and manufacturing capabilities from clinical development to commercialization.

• Assessing Nephrotoxicity And Drug-Drug Interactions

  8/7/2024

  Watch to discover how Organ-on-a-Chip technology can help you overcome the limitations of traditional kidney models and increase your confidence before advancing your drug candidate to the clinic.

• Facts About AAV Producer Cell Lines

  8/8/2025

  Gene therapies are revolutionizing medicine, with AAV vectors leading the way. As production evolves, stable cell lines may replace transient transfection and unlock scalable solutions.

• Assessing Viability And Real-Time Apoptosis/Necrosis

  3/17/2025

  Malignant gliomas are aggressive brain tumors that resist standard treatments. Discover why researchers focus on real-time cell death dynamics to develop targeted therapies and promising strategies.